Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |